B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.

@article{Schnabel2006BtypeNP,
  title={B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.},
  author={Renate B. Schnabel and Edith Lubos and Hans Jurgen Rupprecht and Christine Espinola-Klein and Christoph Bickel and Karl J. Lackner and François Cambien and Laurence Tiret and Thomas F. M{\"u}nzel and Stefan S Blankenberg},
  journal={Journal of the American College of Cardiology},
  year={2006},
  volume={47 3},
  pages={552-8}
}
OBJECTIVES The aim of this study was to assess the predictive value of the cardiac hormone B-type natriuretic peptide (BNP) for long-term outcome in a large cohort of stable angina patients. BACKGROUND Recent data suggest a role of BNP in stable ischemic heart disease beyond its known value in heart failure and acute coronary syndromes. METHODS In 1,085 patients with coronary artery disease (CAD) baseline levels of BNP were prospectively associated with cardiovascular (CV) events during a… CONTINUE READING